IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v8y2017i1d10.1038_ncomms15724.html
   My bibliography  Save this article

Genome-wide association study identifies multiple risk loci for renal cell carcinoma

Author

Listed:
  • Ghislaine Scelo

    (International Agency for Research on Cancer (IARC))

  • Mark P. Purdue

    (National Cancer Institute, National Institutes of Health)

  • Kevin M. Brown

    (National Cancer Institute, National Institutes of Health)

  • Mattias Johansson

    (International Agency for Research on Cancer (IARC))

  • Zhaoming Wang

    (St Jude Children's Research Hospital)

  • Jeanette E. Eckel-Passow

    (Mayo Clinic)

  • Yuanqing Ye

    (The University of Texas MD Anderson Cancer Center)

  • Jonathan N. Hofmann

    (National Cancer Institute, National Institutes of Health)

  • Jiyeon Choi

    (National Cancer Institute, National Institutes of Health)

  • Matthieu Foll

    (International Agency for Research on Cancer (IARC))

  • Valerie Gaborieau

    (International Agency for Research on Cancer (IARC))

  • Mitchell J. Machiela

    (National Cancer Institute, National Institutes of Health)

  • Leandro M. Colli

    (National Cancer Institute, National Institutes of Health)

  • Peng Li

    (International Agency for Research on Cancer (IARC))

  • Joshua N. Sampson

    (National Cancer Institute, National Institutes of Health)

  • Behnoush Abedi-Ardekani

    (International Agency for Research on Cancer (IARC))

  • Celine Besse

    (Centre National de Genotypage, Institut de Genomique, Commissariat à l'Energie Atomique et aux Energies Alternatives)

  • Helene Blanche

    (Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain)

  • Anne Boland

    (Centre National de Genotypage, Institut de Genomique, Commissariat à l'Energie Atomique et aux Energies Alternatives)

  • Laurie Burdette

    (National Cancer Institute, National Institutes of Health)

  • Amelie Chabrier

    (International Agency for Research on Cancer (IARC))

  • Geoffroy Durand

    (International Agency for Research on Cancer (IARC))

  • Florence Le Calvez-Kelm

    (International Agency for Research on Cancer (IARC))

  • Egor Prokhortchouk

    (Center ‘Bioengineering’ of the Russian Academy of Sciences
    Kurchatov Scientific Center)

  • Nivonirina Robinot

    (International Agency for Research on Cancer (IARC))

  • Konstantin G. Skryabin

    (Center ‘Bioengineering’ of the Russian Academy of Sciences
    Kurchatov Scientific Center)

  • Magdalena B. Wozniak

    (International Agency for Research on Cancer (IARC))

  • Meredith Yeager

    (National Cancer Institute, National Institutes of Health)

  • Gordana Basta-Jovanovic

    (Institute of Pathology, School of Medicine, University of Belgrade)

  • Zoran Dzamic

    (Clinical Center of Serbia (KCS), Clinic of Urology, University of Belgrade-Faculty of Medicine)

  • Lenka Foretova

    (Masaryk Memorial Cancer Institute)

  • Ivana Holcatova

    (2nd Faculty of Medicine, Institute of Public Health and Preventive Medicine, Charles University)

  • Vladimir Janout

    (Faculty of Medicine, Palacky University)

  • Dana Mates

    (National Institute of Public Health)

  • Anush Mukeriya

    (Russian N.N. Blokhin Cancer Research Centre)

  • Stefan Rascu

    (Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital)

  • David Zaridze

    (Russian N.N. Blokhin Cancer Research Centre)

  • Vladimir Bencko

    (First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University)

  • Cezary Cybulski

    (International Hereditary Cancer Center, Pomeranian Medical University)

  • Eleonora Fabianova

    (Regional Authority of Public Health in Banska Bystrica)

  • Viorel Jinga

    (Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital)

  • Jolanta Lissowska

    (The M Sklodowska-Curie Cancer Center and Institute of Oncology)

  • Jan Lubinski

    (International Hereditary Cancer Center, Pomeranian Medical University)

  • Marie Navratilova

    (Masaryk Memorial Cancer Institute)

  • Peter Rudnai

    (National Public Health Center, National Directorate of Environmental Health)

  • Neonila Szeszenia-Dabrowska

    (Institute of Occupational Medicine)

  • Simone Benhamou

    (Université Paris Diderot, INSERM, Unité Variabilité Génétique et Maladies Humaines)

  • Geraldine Cancel-Tassin

    (CeRePP, Tenon Hospital
    UPMC Univ Paris 06 GRC n°5)

  • Olivier Cussenot

    (CeRePP, Tenon Hospital
    UPMC Univ Paris 06 GRC n°5)

  • Laura Baglietto

    (Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Université Paris-Saclay, UPS, UVSQ, Gustave Roussy)

  • Heiner Boeing

    (German Institute of Human Nutrition (DIfE) Potsdam-Rehbrücke)

  • Kay-Tee Khaw

    (University of Cambridge)

  • Elisabete Weiderpass

    (Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway
    Cancer Registry of Norway, Institute of Population-Based Cancer Research
    Karolinska Institutet
    Genetic Epidemiology Group, Folkhälsan Research Center)

  • Borje Ljungberg

    (Urology and Andrology, Umeå University)

  • Raviprakash T. Sitaram

    (Urology and Andrology, Umeå University)

  • Fiona Bruinsma

    (Cancer Epidemiology Centre, Cancer Council Victoria)

  • Susan J. Jordan

    (QIMR Berghofer Medical Research Institute
    School of Public Health, The University of Queensland)

  • Gianluca Severi

    (Centre de Recherche en Épidémiologie et Santé des Populations (CESP, Inserm U1018), Université Paris-Saclay, UPS, UVSQ, Gustave Roussy
    Cancer Epidemiology Centre, Cancer Council Victoria
    Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne
    Human Genetics Foundation (HuGeF))

  • Ingrid Winship

    (The University of Melbourne
    Genetic Medicine and Family Cancer Clinic, Royal Melbourne Hospital)

  • Kristian Hveem

    (HUNT Research Centre, Norwegian University of Science and Technology)

  • Lars J. Vatten

    (Faculty of Medicine, Norwegian University of Science and Technology)

  • Tony Fletcher

    (London School of Hygiene and Tropical Medicine, University of London)

  • Kvetoslava Koppova

    (Regional Authority of Public Health in Banska Bystrica)

  • Susanna C. Larsson

    (Institute of Environmental Medicine, Karolinska Institutet)

  • Alicja Wolk

    (Institute of Environmental Medicine, Karolinska Institutet)

  • Rosamonde E. Banks

    (Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital)

  • Peter J. Selby

    (Leeds Institute of Cancer and Pathology, University of Leeds, Cancer Research Building, St James's University Hospital)

  • Douglas F. Easton

    (University of Cambridge
    University of Cambridge)

  • Paul Pharoah

    (University of Cambridge
    University of Cambridge)

  • Gabriella Andreotti

    (National Cancer Institute, National Institutes of Health)

  • Laura E. Beane Freeman

    (National Cancer Institute, National Institutes of Health)

  • Stella Koutros

    (National Cancer Institute, National Institutes of Health)

  • Demetrius Albanes

    (National Cancer Institute, National Institutes of Health)

  • Satu Männistö

    (National Institute for Health and Welfare)

  • Stephanie Weinstein

    (National Cancer Institute, National Institutes of Health)

  • Peter E. Clark

    (Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center)

  • Todd L. Edwards

    (Vanderbilt-Ingram Cancer Center, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University Medical Center)

  • Loren Lipworth

    (Vanderbilt-Ingram Cancer Center, Institute for Medicine and Public Health, Vanderbilt University Medical Center)

  • Susan M. Gapstur

    (American Cancer Society)

  • Victoria L. Stevens

    (American Cancer Society)

  • Hallie Carol

    (Dana-Farber Cancer Institute)

  • Matthew L. Freedman

    (Dana-Farber Cancer Institute)

  • Mark M. Pomerantz

    (Dana-Farber Cancer Institute)

  • Eunyoung Cho

    (Warren Alpert Medical School of Brown University)

  • Peter Kraft

    (Harvard T.H. Chan School of Public Health)

  • Mark A. Preston

    (Brigham and Women's Hospital and VA Boston)

  • Kathryn M. Wilson

    (Harvard T.H. Chan School of Public Health)

  • J. Michael Gaziano

    (Brigham and Women's Hospital and VA Boston)

  • Howard D. Sesso

    (Harvard T.H. Chan School of Public Health
    Brigham and Women's Hospital and VA Boston)

  • Amanda Black

    (National Cancer Institute, National Institutes of Health)

  • Neal D. Freedman

    (National Cancer Institute, National Institutes of Health)

  • Wen-Yi Huang

    (National Cancer Institute, National Institutes of Health)

  • John G. Anema

    (Spectrum Health)

  • Richard J. Kahnoski

    (Spectrum Health)

  • Brian R. Lane

    (Spectrum Health
    College of Human Medicine, Michigan State University)

  • Sabrina L. Noyes

    (Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology)

  • David Petillo

    (Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology)

  • Bin Tean Teh

    (Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology)

  • Ulrike Peters

    (Cancer Prevention Program, Fred Hutchinson Cancer Research Center)

  • Emily White

    (Cancer Prevention Program, Fred Hutchinson Cancer Research Center)

  • Garnet L. Anderson

    (Cancer Prevention Program, Fred Hutchinson Cancer Research Center)

  • Lisa Johnson

    (Cancer Prevention Program, Fred Hutchinson Cancer Research Center)

  • Juhua Luo

    (School of Public Health Indiana University Bloomington)

  • Julie Buring

    (Harvard T.H. Chan School of Public Health
    Brigham and Women's Hospital and VA Boston)

  • I-Min Lee

    (Harvard T.H. Chan School of Public Health
    Brigham and Women's Hospital and VA Boston)

  • Wong-Ho Chow

    (The University of Texas MD Anderson Cancer Center)

  • Lee E. Moore

    (National Cancer Institute, National Institutes of Health)

  • Christopher Wood

    (The University of Texas M.D. Anderson Cancer Center)

  • Timothy Eisen

    (Cambridge University Hospitals NHS Foundation Trust)

  • Marc Henrion

    (Icahn School of Medicine at Mount Sinai)

  • James Larkin

    (Medical Oncology, Royal Marsden NHS Foundation Trust)

  • Poulami Barman

    (Mayo Clinic)

  • Bradley C. Leibovich

    (Mayo Medical School and Mayo Clinic)

  • Toni K. Choueiri

    (Dana-Farber Cancer Institute)

  • G. Mark Lathrop

    (McGill University and Genome Quebec Innovation Centre)

  • Nathaniel Rothman

    (National Cancer Institute, National Institutes of Health)

  • Jean-Francois Deleuze

    (Centre National de Genotypage, Institut de Genomique, Commissariat à l'Energie Atomique et aux Energies Alternatives
    Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain)

  • James D. McKay

    (International Agency for Research on Cancer (IARC))

  • Alexander S. Parker

    (Mayo Clinic)

  • Xifeng Wu

    (The University of Texas MD Anderson Cancer Center)

  • Richard S. Houlston

    (The Institute of Cancer Research
    The Institute of Cancer Research)

  • Paul Brennan

    (International Agency for Research on Cancer (IARC))

  • Stephen J. Chanock

    (National Cancer Institute, National Institutes of Health)

Abstract

Previous genome-wide association studies (GWAS) have identified six risk loci for renal cell carcinoma (RCC). We conducted a meta-analysis of two new scans of 5,198 cases and 7,331 controls together with four existing scans, totalling 10,784 cases and 20,406 controls of European ancestry. Twenty-four loci were tested in an additional 3,182 cases and 6,301 controls. We confirm the six known RCC risk loci and identify seven new loci at 1p32.3 (rs4381241, P=3.1 × 10−10), 3p22.1 (rs67311347, P=2.5 × 10−8), 3q26.2 (rs10936602, P=8.8 × 10−9), 8p21.3 (rs2241261, P=5.8 × 10−9), 10q24.33-q25.1 (rs11813268, P=3.9 × 10−8), 11q22.3 (rs74911261, P=2.1 × 10−10) and 14q24.2 (rs4903064, P=2.2 × 10−24). Expression quantitative trait analyses suggest plausible candidate genes at these regions that may contribute to RCC susceptibility.

Suggested Citation

  • Ghislaine Scelo & Mark P. Purdue & Kevin M. Brown & Mattias Johansson & Zhaoming Wang & Jeanette E. Eckel-Passow & Yuanqing Ye & Jonathan N. Hofmann & Jiyeon Choi & Matthieu Foll & Valerie Gaborieau &, 2017. "Genome-wide association study identifies multiple risk loci for renal cell carcinoma," Nature Communications, Nature, vol. 8(1), pages 1-9, August.
    • Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15724
    DOI: 10.1038/ncomms15724
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms15724
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/ncomms15724?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Karl Smith-Byrne & Åsa Hedman & Marios Dimitriou & Trishna Desai & Alexandr V. Sokolov & Helgi B. Schioth & Mine Koprulu & Maik Pietzner & Claudia Langenberg & Joshua Atkins & Ricardo Cortez Penha & J, 2024. "Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    2. Molly Went & Amit Sud & Charlie Mills & Abi Hyde & Richard Culliford & Philip Law & Jayaram Vijayakrishnan & Ines Gockel & Carlo Maj & Johannes Schumacher & Claire Palles & Martin Kaiser & Richard Hou, 2024. "Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
    3. Huanhuan Cui & Hongyang Yi & Hongyu Bao & Ying Tan & Chi Tian & Xinyao Shi & Diwen Gan & Bin Zhang & Weizheng Liang & Rui Chen & Qionghua Zhu & Liang Fang & Xin Gao & Hongda Huang & Ruijun Tian & Silk, 2022. "The SWI/SNF chromatin remodeling factor DPF3 regulates metastasis of ccRCC by modulating TGF-β signaling," Nature Communications, Nature, vol. 13(1), pages 1-16, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15724. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.